-- 瑞銀表示,已將油價的最新走勢納入其對加拿大通膨的預測,並採用了原油期貨暗示的最新路徑:布蘭特原油5月合約價格將達到每桶118美元,預計到年底將穩定在每桶78美元左右,到2027年底將穩定在每桶73美元左右。 基於此,瑞銀目前預估今年加拿大整體通膨率為2.9%,2027年為2.4%。瑞銀預計3月加拿大整體通膨率將強勁上漲1.3%(未季節性調整),使年比通膨率在3月上升1個百分點至2.8%。 瑞銀預測,整體通膨率將在4月達到高峰3.4%,之後將回落。 在瑞銀的成長預測中,預計出口成長將加快,但下調了企業固定投資和消費預期。 整體而言,該行的年度預測變化不大,預計今年年增長率為1.6%,2027年為1.7%。 最新的月度國內生產毛額(GDP)數據顯示,今年開局尚可,1月份GDP環比增長0.1%,略優於此前預估的持平數據;2月份的預估環比增長0.2%。 繼2月就業人數全面大幅下降之後,瑞銀預測3月就業人數將溫和成長1.6萬人,預計週五公佈的就業數據顯示,失業率將維持在6.7%不變。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.